Stratos Wealth Advisors LLC Sells 9,638 Shares of Crocs, Inc. $CROX

Stratos Wealth Advisors LLC cut its holdings in Crocs, Inc. (NASDAQ:CROXFree Report) by 52.1% in the third quarter, HoldingsChannel reports. The firm owned 8,867 shares of the textile maker’s stock after selling 9,638 shares during the period. Stratos Wealth Advisors LLC’s holdings in Crocs were worth $741,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CROX. Boston Partners lifted its position in shares of Crocs by 2,659.1% in the second quarter. Boston Partners now owns 1,688,383 shares of the textile maker’s stock worth $171,003,000 after buying an additional 1,627,190 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Crocs by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 1,180,405 shares of the textile maker’s stock valued at $119,551,000 after acquiring an additional 64,672 shares in the last quarter. LSV Asset Management lifted its holdings in Crocs by 21.9% in the 2nd quarter. LSV Asset Management now owns 1,073,120 shares of the textile maker’s stock worth $108,686,000 after purchasing an additional 192,860 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in Crocs by 4.2% during the second quarter. Thrivent Financial for Lutherans now owns 768,304 shares of the textile maker’s stock worth $77,814,000 after purchasing an additional 31,083 shares during the period. Finally, Patient Capital Management LLC grew its holdings in Crocs by 17.0% during the third quarter. Patient Capital Management LLC now owns 588,794 shares of the textile maker’s stock valued at $49,194,000 after purchasing an additional 85,416 shares during the last quarter. 93.44% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CROX. Weiss Ratings upgraded shares of Crocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Monness Crespi & Hardt boosted their target price on shares of Crocs from $100.00 to $130.00 and gave the stock a “buy” rating in a research report on Friday. Bank of America decreased their price target on shares of Crocs from $99.00 to $98.00 and set a “buy” rating for the company in a report on Tuesday, October 21st. Barclays lifted their price objective on Crocs from $86.00 to $109.00 and gave the stock an “equal weight” rating in a research note on Friday. Finally, The Goldman Sachs Group increased their target price on Crocs from $71.00 to $81.00 and gave the company a “sell” rating in a research note on Friday. Four investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Crocs has a consensus rating of “Hold” and a consensus price target of $104.09.

Get Our Latest Analysis on CROX

Crocs Stock Down 1.6%

Shares of CROX opened at $96.88 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.83 and a current ratio of 1.27. The company has a 50-day simple moving average of $86.81 and a 200-day simple moving average of $84.70. Crocs, Inc. has a 52 week low of $73.21 and a 52 week high of $122.84. The firm has a market capitalization of $5.03 billion, a P/E ratio of -76.89 and a beta of 1.56.

Crocs (NASDAQ:CROXGet Free Report) last issued its quarterly earnings results on Thursday, February 12th. The textile maker reported $2.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.37. Crocs had a positive return on equity of 45.17% and a negative net margin of 2.01%.The firm had revenue of $957.64 million for the quarter, compared to analyst estimates of $916.16 million. During the same period in the previous year, the company posted $2.52 earnings per share. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Crocs has set its FY 2026 guidance at 12.880-13.350 EPS and its Q1 2026 guidance at 2.670-2.770 EPS. On average, equities research analysts expect that Crocs, Inc. will post 13.2 earnings per share for the current year.

Key Stories Impacting Crocs

Here are the key news stories impacting Crocs this week:

About Crocs

(Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

Further Reading

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROXFree Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.